Cardiac Imaging and Ablation for Arrhythmia and Cardiomyopathy
This community focuses on non-invasive imaging techniques and catheter-based interventions to diagnose and treat heart rhythm disorders and structural heart diseases.
The work centers on cardiac magnetic resonance imaging, particularly late gadolinium enhancement and myocardial perfusion sequences, alongside computed tomography for coronary artery assessment. These imaging modalities are applied to diagnose hypertrophic and dilated cardiomyopathy, cardiac amyloidosis, and myocardial infarction. A significant portion of the research involves pulsed field ablation and radiofrequency ablation for atrial fibrillation, with recent studies comparing these techniques. The community also integrates artificial intelligence and deep learning models to analyze imaging data and improve diagnostic accuracy for conditions like heart failure and cardiac sarcoidosis.
The community represents 21.5% of all tracked thallium research, 20.1% of technetium research, and 10.3% of gadolinium research. It contains 2,346 papers in the gadolinium element group, 1,250 in technetium, and 954 in thallium.
The community comprises 12,770 papers, published primarily in the Journal of Nuclear Cardiology, the European Journal of Nuclear Medicine and Molecular Imaging, and the Journal of the American College of Cardiology.
Recent work includes large multicenter safety studies on pulsed field ablation for atrial fibrillation, consensus statements on managing atrial tachycardia, and comparative trials between pulsed field and radiofrequency ablation.
Papers behind this description
- Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study — Nature Medicine, 2024 — doi:10.1038/s41591-024-03114-3
- Cardiovascular Diseases (CVDs) — 2022 — doi:10.1002/9781118910573.ch5
- Myocardial Strain Imaging — JACC: Cardiovascular Imaging, 2025 — doi:10.1016/j.jcmg.2024.07.011
- Heart Failure With Preserved Ejection Fraction — JAMA, 2023 — doi:10.1001/jama.2023.2020
- Atrial cardiomyopathy revisited—evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS) — EP Europace, 2024 — doi:10.1093/europace/euae204
- Pulsed Field or Cryoballoon Ablation for Paroxysmal Atrial Fibrillation — New England Journal of Medicine, 2025 — doi:10.1056/nejmoa2502280
- 2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis — Journal of the American College of Cardiology, 2023 — doi:10.1016/j.jacc.2022.11.022
- 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation — Heart Rhythm, 2024 — doi:10.1016/j.hrthm.2024.03.017
- Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis — New England Journal of Medicine, 2023 — doi:10.1056/nejmoa2300757
- State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective — EP Europace, 2024 — doi:10.1093/europace/euae134
- 2024 Update in Heart Failure — ESC Heart Failure, 2024 — doi:10.1002/ehf2.14857
- Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients — Journal of the American College of Cardiology, 2025 — doi:10.1016/j.jacc.2025.10.051
- Management of patients with atrial tachycardia: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), and the Association for European Paediatric and Congenital Cardiology (AEPC) — EP Europace, 2025 — doi:10.1093/europace/euaf324
- Pulsed field vs radiofrequency ablation for paroxysmal atrial fibrillation: the BEAT PAROX-AF trial — European Heart Journal, 2026 — doi:10.1093/eurheartj/ehaf1115
- Pulsed field ablation for atrial fibrillation ablation: a European Heart Rhythm Association survey — EP Europace, 2025 — doi:10.1093/europace/euaf294
- Sepsis-Induced Cardiomyopathy and Cardiac Arrhythmias: Pathophysiology and Implications for Novel Therapeutic Approaches — Biomedicines, 2025 — doi:10.3390/biomedicines13112643
- Hypercontractility and Oxidative Stress Drive Creatine Kinase Dysfunction in Hypertrophic Cardiomyopathy — Circulation, 2025 — doi:10.1161/circulationaha.125.074120